Nasdaq: CYTK
Cytokinetics insiders
The officers, directors and 10% owners of Cytokinetics, Incorporated who hold the most stock, valued at the live CYTK price.
$51.46
CYTK today +$140K (+0.27%)
Market closed. Prices as of Nov 19, 4:04 PM ET
- Ranked insiders
- 7
- Their CYTK stock
- $42.5M
- Market value
- $7.17B
- Held by ranked insiders
- 0.59%
Insiders by value of CYTK holdings
SEC ownership page| # | Insider | Role | Shares | Value | Of company | Overall rank |
|---|---|---|---|---|---|---|
| 1 | Robert I. Blum | President & CEO | 280,627 | $14.4M | 0.20% | 6643rd |
| 2 | Fady Ibraham Malik | EVP Research & Development | 153,902 | $7.9M | 0.11% | 10352nd |
| 3 | David Cragg | Chief HR & Admin Officer | 153,233 | $7.9M | 0.11% | 10468th |
| 4 | Mark A. Schlossberg | SVP - Legal & General Counsel | 103,408 | $5.3M | <0.1% | 13856th |
| 5 | Jeffrey Hessekiel | Chief Legal & Admin Officer | 92,837 | $4.8M | <0.1% | 2526th |
| 6 | Brett A. Pletcher | EVP, Chief Legal Officer | 33,140 | $1.7M | <0.1% | 11109th |
| 7 | Robert E. Landry | Director | 8,184 | $421K | <0.1% | 4735th |
Only insiders worth at least $5 million in listed stock are ranked. Holdings come from each insider's latest Form 3, 4 or 5 for Cytokinetics; see each profile for the filing.